Evidence map›Paper›PMID 19513752›Full record

ArticleHuman genetics2009

Megakaryoblastic leukemia factor-1 gene in the susceptibility to coronary artery disease.

Kunihiko Hinohara, Toshiaki Nakajima, Michio Yasunami, Shigeru Houda, Taishi Sasaoka, Ken Yamamoto, Bok-Soo Lee, Hiroki Shibata, Yumiko Tanaka-Takahashi, Megumi Takahashi and 10 more

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Human genetics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Kunihiko HinoharaDepartment of Molecular Pathogenesis, Medical Research Institute, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan.
Toshiaki Nakajima
Michio Yasunami
Shigeru Houda
Taishi Sasaoka
Ken Yamamoto
Bok-Soo Lee
Hiroki Shibata
Yumiko Tanaka-Takahashi
Megumi Takahashi
Takuro Arimura
Akinori Sato
Taeko Naruse
Jimin Ban
Hidetoshi Inoko
Yoshiji Yamada
Motoji Sawabe
Jeong-Euy Park
Toru Izumi
Akinori Kimura

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronary artery disease (CAD) is based on the atherosclerosis of coronary artery and may manifest with myocardial infarction or angina pectoris. Although it is widely accepted that genetic factors are linked to CAD and several disease-related genes have been reported, only a few could be replicated suggesting that there might be some other CAD-related genes. To identify novel susceptibility loci for CAD, we used microsatellite markers in the screening and found six different candidate CAD loci. Subsequent single nucleotide polymorphism (SNP) association studies revealed an association between CAD and megakaryoblastic leukemia factor-1 gene (MKL1). The association with a promoter SNP of MKL1, -184C > T, was found in a Japanese population and the association was replicated in another Japanese population and a Korean population. Functional analysis of the MKL1 promoter SNP suggested that the higher MKL1 expression was associated with CAD. These findings suggest that MKL1 is involved in the pathogenesis of CAD.

Indexed as

AdultAgedB-LymphocytesCase-Control StudiesCells, CulturedCoronary Artery DiseaseDisease SusceptibilityDNA-Binding ProteinsDNA PrimersFemaleGenetic TestingGenotypeHumansJapanKoreaMaleDNA-Binding ProteinsDNA PrimersMRTFA protein, humanOncogene Proteins, FusionRNA, MessengerTrans-Activators

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.